BGB-3111 - CAS 1633350-06-7
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C27H29N5O3
Molecular Weight:
471.55
COA:
Inquire
Targets:
BTK
Description:
BGB-3111 is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher exposure and more complete target inhibition in the tissues than ibrutinib.
Synonyms:
2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-1,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide; SCHEMBL16208602; BDBM249900
Solubility:
DMSO
Storage:
Store in a cool and dry place (or refer to the Certificate of Analysis).
MSDS:
Inquire
Boiling Point:
713.4±60.0 ℃ at 760 Torr
Density:
1.33±0.1 g/cm3
InChIKey:
QRTMNNHEGPFUPS-UHFFFAOYSA-N
InChI:
1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,30H,1,12-17H2,(H2,28,34)
Canonical SMILES:
C=CC(=O)N1CCC(CC1)C2CCN=C3N2NC(=C3C(=O)N)C4=CC=C(C=C4)OC5=CC=CC=C5
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related BTK Products


CAS 1415823-73-2 Evobrutinib

Evobrutinib
(CAS: 1415823-73-2)

Evobrutinib is a highly selective inhibitor of Bruton's tyrosin kinase (Btk) inhibitor.

CAS 1553977-42-6 Btk inhibitor 1 R enantiomer hydrochloride

Btk inhibitor 1 R enantiomer hydrochlori
(CAS: 1553977-42-6)

Btk inhibitor 1R enantiomer Hcl is a&nbsp; pyrazolo[3,4-d]pyrimidine derivative as a <strong>Btk </strong>kinase inhibitor.

CAS 1412418-47-3 Btk inhibitor 1

Btk inhibitor 1
(CAS: 1412418-47-3)

Btk inhibitor 1 is a pyrazolo[3,4-d]pyrimidine derivative as a Btk kinase inhibitor.

CAS 1439901-97-9 ONO-4059 (hydrochloride)

ONO-4059 (hydrochloride)
(CAS: 1439901-97-9)

ONO-4059 (hydrochloride) is the hydrochloride salt form of Tirabrutinib. ONO-4059 is a highly selective, orally bioavailable BTK inhibitor (IC50= 2.2 nM) and de...

CAS 1242156-23-5 RN486

RN486
(CAS: 1242156-23-5)

RN486 is a reversible Bruton's tyrosine kinase (Btk) inhibitor with IC50 value of 4.0 nM.

CAS 121-40-4 (-)-Terreic acid

(-)-Terreic acid
(CAS: 121-40-4)

(-)-Terreic acid is a selective inhibitor of Bruton's tyrosine kinase (BTK) with antibiotic activity. (-)-Terreic acid inhibits the catalytic activity of BTK an...

CAS 1353550-13-6 Olmutinib

Olmutinib
(CAS: 1353550-13-6)

Olmutinib, also called as HM61713 and BI-1482694, is an orally available, mutant-selective third-generation epidermal growth factor receptor tyrosine kinase inh...

CAS 936563-87-0 PCI-32765 Racemate

PCI-32765 Racemate
(CAS: 936563-87-0)

PCI-32765 Racemate is a potent and highly selective inhibitor of Bruton tyrosine kinase (BTK), modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, ...

CAS 1022150-12-4 Btk inhibitor 1 R enantiomer

Btk inhibitor 1 R enantiomer
(CAS: 1022150-12-4)

Btk inhibitor 1 R enantiomer is a pyrazolo[3,4-d]pyrimidine derivative as a Btk kinase inhibitor.

ONO-4059
(CAS: 1351636-18-4)

ONO-4059, a BTK inhibitor, has been found to have potential effect against sorts of malignancies by influencing the B-cell development. It is currently under Ph...

Acalabrutinib
(CAS: 1420477-60-6)

Acalabrutinib, also known as ACP-196, is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. It inhibits the...

CAS 1202757-89-8 AVL-292

AVL-292
(CAS: 1202757-89-8)

AVL-292, also known as CC-292, is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplas...

CAS 910232-84-7 CGI1746

CGI1746
(CAS: 910232-84-7)

CGI1746 is a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation. CGI1746 has exqui...

RN983
(CAS: 1423129-83-2)

RN983 is a selective BTK enzyme inhibitor. It inhibits IgG production in B-cells with an IC50 value of 2.5 ± 0.7 nM and PGD2 production from mast cells with an ...

CAS 1469988-75-7 QL47

QL47
(CAS: 1469988-75-7)

QL47 is a potent and selective BTK inhibitor, which covalently modifies Cys481. QL47 inhibits BTK kinase activity with an IC50 of 7 nM, inhibits autophosphoryla...

CAS 1633350-06-7 BGB-3111

BGB-3111
(CAS: 1633350-06-7)

BGB-3111 is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher ...

CAS 1133432-49-1 GDC-0837

GDC-0837
(CAS: 1133432-49-1)

GDC-0834 is a small molecule inhibitor of Btk potentially useful in the treatment of RA and lymphoid malignancies. Administration of GDC-0834 (30 -- 100 mg/kg)...

CAS 1202759-32-7 CNX-774

CNX-774
(CAS: 1202759-32-7)

CNX-774 is a potent Btk inhibitor (IC50 < 1 nM)

CAS 1360053-81-1 AVL-292 benzenesulfonate

AVL-292 benzenesulfonate
(CAS: 1360053-81-1)

AVL-292 benzenesulfonate is a covalent, highly selective, orally active small molecule inhibitor of Btk with IC50 value of 0.5 nM; &gt;1400-fold selectivity ove...

CAS 330786-25-9 PCI 29732

PCI 29732
(CAS: 330786-25-9)

Potent BTK inhibitor (IC50 = 0.3 nM). Blocks B cell antigen receptor (BCR)-mediated gene expression in CD20+ B cells.

Chemical Structure

CAS 1633350-06-7 BGB-3111

Quick Inquiry

Verification code

Featured Items